{
    "id": 20981,
    "cites": 18,
    "cited_by": 4,
    "reference": [
        "Ackerberg, D. A. (2003). Advertising, Learning, and Consumer Choice in Experience Good Markets: An Empirical Examination. International Economic Review, 44(3):1007\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1040.",
        "Berry, S. T. (1994). Estimating discrete-choice models of product differentiation. RAND Journal of Economics, 25(2):242\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c262.",
        "Budish, E., Roin, B., and Williams, H. (2015). Do fixed patent terms distort innovation? evidence from cancer clinical trials. American Economic Review, forthcoming.",
        "Ching, A. T. (2010). A dynamic oligopoly structural model for the prescription drug market after patent expiration. International Economic Review, 51(4):1175\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1207.",
        "Cohen, A. and Einav, L. (2007). Estimating risk preferences from deductible choice. The American Economic Review, pages 745\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c788.",
        "Crawford, G. S. and Shum, M. (2005). Uncertainty and learning in pharmaceutical demand.",
        "Dranove, D. and Jin, G. (2010). Quality disclosure and certification: Theory and practice. Journal of Economic Literature, 48(4):935\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c63.",
        "Erdem, T. and Keane, M. P. (1996). Decision-Making Under Uncertainty: Capturing Dynamic Brand Choice Processes in Turbulent Consumer Goods Markets. Marketing Science, 15(1):1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 20.",
        "Filson, D. (2012). A markov-perfect equilibrium model of the impacts of price controls on the performance of the pharmaceutical industry. RAND Journal of Economics, 43(1):110\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c138.",
        "Grennan, M. (2013). Price discrimination and bargaining: Empirical evidence from medical devices. American Economic Review, 103(1):145\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c177.",
        "Grennan, M. (2014). Bargaining ability and competitive advantage: Empirical evidence from medical devices. forthcoming in Management Science.",
        "Lee, R. S. and Fong, K. (2013). Markov-perfect network formation an applied framework for bilateral oligopoly and bargaining in buyer-seller networks. working paper.",
        "Makower, J., Meer, A., and Denend, L. (2010). FDA impact of us medical technology innovation: A survey of over 200 medical technology companies. Stanford University Report.",
        "Miravete, E. J., Seim, K., and Thurk, J. (2014). Complexity, Efficiency, and Fairness in MultiProduct Monopoly Pricing. Technical report, Working paper.",
        "Murphy, K. and Topel, R. (2006). The value of health and longevity. Journal of Political Economy, 114(3):871\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c904.",
        "Peltzman, S. (1973). An evaluation of consumer protection legislation: The 1962 drug amendments.",
        "Roberts, J. H. and Urban, G. L. (1988). Modeling multiattribute utility, risk, and belief dynamics for new consumer durable brand choice. Management Science, 34(2):167\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c185.",
        "Seim, K. and Waldfogel, J. (2013). Public monopoly and economic efficiency: Evidence from the pennsylvania liquor control board\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s entry decisions. American Economic Review, 103(2):831\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 62."
    ]
}